At CiteAb we work hard to get to know individual antibody suppliers so that you can be sure the data we hold is always up to date and correct. Every now and then we feature individual company highlights here on our blog, allowing you to get to know leading antibody suppliers too.
We recently mentioned Badrilla as one of our runners-up in the 2014 CiteAb Antibody Awards, in our ‘Small Company of the Year’ category. The category was created to show that big isn’t always best and the award recognised small companies with a maximum of 1000 antibodies in their portfolio and with the most citations per antibody.
Badrilla’s slogan is ‘enabling cardiovascular research’ and it specialises in the generation and validation of phosphospecific antibodies to cardiovascular targets. In addition, the company is developing antibodies to fluorescent proteins.
Based in Leeds, UK, Badrilla was founded in 2003 by Professor John Colyer, a cardiovascular expert at the University of Leeds.
Over the past ten years Badrilla products have helped to underpin key discoveries in cardiac biochemistry and the company has garnered a wealth of published data from respected scientists worldwide – demonstrating the effectiveness of its products.
If you’d like to meet the Badrilla team and learn more about the company, you’ll find them at many of the smaller, more focussed scientific meetings taking place this year. The company favours these as opportunities to keep up-to-date and closely aligned with key developments in the cardiovascular field, and would be pleased to meet anyone interested in learning more about its products.
We are always looking for new companies and academics to share their antibody data with us, so if you have antibodies that are not listed on CiteAb do get in touch.
– Matt and the CiteAb team